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ONLINE SUPPLEMENTAL MATERIAL  
Supplementary Figure S1 – Phylum relative abundances of intervention and 
control groups. (i) Phylum relative abundances, with inset plots representing phyla in 
which a significant difference between HFC and another group has been identified. * 
(p < 0.05) and ** (p < 0.01) represent significant differences recorded between HFC 
and one of the interventions, or NC. Plots depict individual replicates with mean and 
SEM, and dashed lines depict the HFC mean for use as comparison. 
Supplementary Figure S2 – Family relative abundances of intervention and 
control groups. Column A inset plots represent families that contain species capable 
of converting choline into pro-atherogenic TMA. Column B represents families 
containing species known to produce SCFA, which interact with host cardiometabolic 
health. Column C represents families containing other species of interest for host 
metabolic and immunological health. * (p < 0.05) and ** (p < 0.01) represent significant 
differences recorded between HFC and one of the interventions, or NC. Plots depict 
individual replicates with mean and SEM, and dashed lines depict the HFC mean for 
use as comparison. 
Supplementary Figure S3 – Genus relative abundances of intervention and 
control groups. Genus relative abundances, with inset plots representing genera in 
which a significant difference between HFC and another group has been identified. * 
(p < 0.05) and ** (p < 0.01) represent significant differences recorded between HFC 
and one of the interventions, or NC. Plots depict individual replicates with mean and 
SEM, and dashed lines depict the HFC mean for use as comparison. 
Supplementary Figure S4 – Faecal metabolome important features associated 
with each cardiovascular disease intervention. The faecal metabolites found to be 
most important in explaining shifts in PLS-DA for each intervention (PSE [A], OBG [B], 
BSH [C] and STAT [D]) when compared to the HFC. 
Supplementary Figure S5 – Serum metabolome important features associated 
with each cardiovascular disease intervention. The serum metabolites found to be 
most important in explaining shifts in PLS-DA for each intervention (PSE [A], OBG [B], 
BSH [C] and STAT [D]) when compared to the HFC. 
Supplementary Figure S6 – Correlation heatmap containing physiological, 
microbiome and faecal metabolome data.  
Supplementary Figure S7 – Correlation coefficient analysis plots of primary 
physiological outcomes with microbiome and faecal metabolome. Several 
important metabolic markers are displayed with the microbial taxa and metabolites 
most correlated (Cholesterol [A], Plaque [B], TAG [C] and IAP [D]). * FDR adjusted p < 
0.05. 
Supplementary Table S1 – Alpha diversity of intervention and control groups. 
Means in a row with common superscripts do not differ (P ≥ 0.05). 
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  PSE OBG BSH STAT HFC NC 
Chao1 276.75 bc 299.85 bc 266.90 c 290.15 bc 315.39 bc 443.73 a 
Simpsons 0.95 ab 0.95 ab 0.93 b 0.95 ab 0.96 ab 0.97 a 
Shannon 5.30 bc 5.39 bc 5.09 c 5.31 bc 5.62 bc 6.13 a 
PD Whole Tree 13.96 d 15.85 bc 13.85 d 14.53 cd 16.39 b 22.45 a 
Observed 
Species 
230.33 cd 259.88 bc 218.50 d 238.08 cd 271.64 b 397.14 a 
